Manufacturing roundup: Juno Pharmaceuticals acquires Omega Laboratories; Pfizer halts distribution of four medicines
Juno Pharmaceuticals has acquired the injectable pharmaceutical manufacturer Omega Laboratories.
The deal gives Juno one of Canada’s largest injectable manufacturers, which is expected to transform it into one of Canada’s largest specialty generic injectable producers with domestic manufacturing abilities.
Juno also plans to bring more than 100 new products to Canada over the next four years, mainly treatments for pain management, allergies, and weight loss. Financial details of the deal were not disclosed.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters